DJIA 17,191.37 -195.84 -1.13%
NASDAQ 4,637.99 -43.50 -0.93%
S&P 500 2,002.16 -27.39 -1.35%
market minute promo

4.56 -0.22 (-4.51%)

REAL-TIME: Last trade at

Extended Hours: $4.56 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

ARNA $4.56 -4.51%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.77
Previous Close $4.77
Daily Range $4.53 - $4.86
52-Week Range $3.26 - $7.36
Market Cap $1.0B
P/E Ratio -19.88
Dividend (Yield) $0.00 (0.0%)
Volume 4,720,688
Average Daily Volume 12,624,493
Current FY EPS -$0.26

Sector

Healthcare

Industry

Drugs

Arena Pharmaceuticals, Inc. (ARNA) Description

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Website: http://www.arenapharm.com/

News & Commentary

Newly Approved Weight Loss Method Works by Tricking Your Brain

What's the best way to lose weight? One company thinks it's simple: don't get hungry.

Arena - Flat Scripts Is Not A Good Start To 2015

Contrave Scripts Continue Increases For Orexigen

Seeking Alpha's Biotech Weekly: Salix Sale Murmurs, A Very Active CHMP, And More

Arena's Belviq Prescriptions Fall: More Publicity Is Needed

Biotech Stock Mailbag: Arena Pharma, Agenus, EnteroMedics

Arena Pharmaceuticals to Raise Fund Via Share Issuance - Analyst Blog

CNBC's Stock Pops & Drops From January 21

Belviq IMS Gains Consistent With Symphony

Mid-Afternoon Market Update: Alnylam Pharmaceuticals Drops Following Equity Offering; Insperity Shar

Mid-Afternoon Market Update: Alnylam Pharmaceuticals Drops Following Equity Offering; Insperity Shares Spike Higher

See More ARNA News...

ARNA's Top Competitors

ARNA $4.56 (-4.51%)
Current stock: ARNA
AMGN $154.64 (-2.67%)
Current stock: AMGN
GILD $102.45 (-2.46%)
Current stock: GILD
BIIB $351.18 (-1.87%)
Current stock: BIIB